Corteva, Inc. $CTVA Shares Purchased by Jones Financial Companies Lllp

Jones Financial Companies Lllp grew its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 17.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 119,068 shares of the company’s stock after purchasing an additional 17,875 shares during the quarter. Jones Financial Companies Lllp’s holdings in Corteva were worth $8,104,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Brighton Jones LLC raised its holdings in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares during the last quarter. Woodline Partners LP grew its position in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. Wealthcare Advisory Partners LLC acquired a new stake in shares of Corteva in the second quarter valued at approximately $213,000. KLP Kapitalforvaltning AS lifted its position in Corteva by 6.2% during the second quarter. KLP Kapitalforvaltning AS now owns 251,676 shares of the company’s stock worth $18,757,000 after buying an additional 14,600 shares in the last quarter. Finally, Joel Isaacson & Co. LLC acquired a new position in Corteva during the second quarter worth $228,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Down 3.5%

NYSE:CTVA opened at $72.50 on Friday. The stock has a fifty day simple moving average of $68.72 and a 200-day simple moving average of $68.43. The company has a market capitalization of $48.99 billion, a PE ratio of 45.89, a price-to-earnings-growth ratio of 1.86 and a beta of 0.75. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The company has a quick ratio of 1.07, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Analyst Ratings Changes

A number of brokerages have issued reports on CTVA. Oppenheimer set a $86.00 target price on Corteva in a research note on Thursday. Wolfe Research raised their price objective on shares of Corteva from $80.00 to $81.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and boosted their target price for the company from $75.00 to $77.00 in a report on Thursday. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price objective on shares of Corteva in a research report on Thursday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $81.84.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: RBC raised its price target to $89 and kept an “outperform” rating, signaling sizable upside from current levels and supporting bullish investor views. RBC raises price target
• Positive Sentiment: Management raised FY‑2026 EPS guidance to $3.45–$3.70 (above Street consensus ~3.23) and the company highlighted record free cash flow and a strong second half, which underpin longer‑term earnings visibility. Guidance and metrics Earnings highlights
• Neutral Sentiment: Analyst views are mixed across the sector, with some firms more cautious and others bullish — adding to day‑to‑day volatility as investors weigh differing valuations and demand outlooks. Conflicting analyst sentiments
• Neutral Sentiment: Full earnings materials and the call transcript are available; they show operational detail that investors will parse (product mix, regional timing) — useful for medium‑term positioning but containing both upside and downside signals. Earnings transcript
• Negative Sentiment: JPMorgan downgraded CTVA from “overweight” to “neutral,” citing limited valuation upside despite raising its target slightly to $77 — a headline catalyst for selling pressure. JPMorgan downgrade
• Negative Sentiment: Corteva missed Q4 revenue expectations as seasonal timing shifts and weaker crop protection/seed demand weighed, and the company reported a wider loss after hours — immediate negative for near‑term sentiment and the main driver of the intraday drop. Revenue miss article After-hours reaction

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.